GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer

L Molina, CD Figueroa, KD Bhoola… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Breast cancer is clinically classified as 'estrogen-positive'when at least 1% of
cancer cells stain for the estrogen receptor alpha (ERα). However, recent research on both …

[PDF][PDF] GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer

L Molina, CD Figueroa, KD Bhoola, P Ehrenfeld - 2017 - researchgate.net
Introduction: Breast cancer is clinically classified as Lestrogen-positiveL when at least 1% of
cancer cells stain for the estrogen receptor alpha (ERα). However, recent research on both …

GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer

L Molina, CD Figueroa, KD Bhoola… - Expert opinion on …, 2017 - pubmed.ncbi.nlm.nih.gov
Breast cancer is clinically classified as' estrogen-positive'when at least 1% of cancer cells
stain for the estrogen receptor alpha (ERα). However, recent research on both basic and …

GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer.

L Molina, CD Figueroa, KD Bhoola… - Expert Opinion on …, 2017 - europepmc.org
Breast cancer is clinically classified as' estrogen-positive'when at least 1% of cancer cells
stain for the estrogen receptor alpha (ERα). However, recent research on both basic and …

[PDF][PDF] GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer

L Molina, CD Figueroa, KD Bhoola, P Ehrenfeld - 2017 - researchgate.net
Introduction: Breast cancer is clinically classified as Lestrogen-positiveL when at least 1% of
cancer cells stain for the estrogen receptor alpha (ERα). However, recent research on both …